Latest Shareholder Vote News

Patriot Resources has successfully raised $2.2 million through an oversubscribed share placement, signaling strong investor confidence as it advances exploration in Zambia and other projects.

Trinex Minerals Limited has announced a significant 127:1 security consolidation affecting its ordinary shares, options, and performance rights, pending shareholder approval and set to reshape its capital structure by mid-July.

EQ Resources Limited has successfully raised $18.8 million through a share placement, complemented by a $3 million Share Purchase Plan, to fund its tungsten mining projects and reduce debt.

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

Carbine Resources Limited has announced a pro-rata entitlement offer aiming to raise approximately $1.1 million to fund exploration and working capital. The offer includes broker options subject to shareholder approval and targets shareholders in select jurisdictions.

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

The Takeovers Panel has issued interim orders compelling Emu NL to submit all proxy forms from its recent extraordinary general meeting, including those disallowed, as part of an ongoing dispute initiated by Wayburn Holdings.

Gold Road Resources has secured a crucial regulatory green light as the Foreign Investment Review Board approves Gold Fields’ acquisition scheme. The deal now moves closer to shareholder and court approvals.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Andromeda Metals has successfully raised $5 million through a share placement to institutional investors, aiming to accelerate development of its Great White and HPA projects. The company also plans to issue options that could inject further capital if exercised.

Uvre Limited is set to acquire New Zealand gold explorer Otagold, backed by a $4 million equity raise and the appointment of mining veterans Norman Seckold and Peter Nightingale to its board.